Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function

European Journal of Neuroscience

Volumn 13, Issue 5, 2001, Pages 889-898

  Lucas, Guillaume ^a   Di Matteo, Vincenzo ^b   De Deurwaerdère, Philippe ^a   Porras, Grégory ^a   Martín Ruiz, Raúl ^c   Artigas, Francesc ^c   Esposito, Ennio ^b   Spampinato, Umberto ^a  

^a CNRS   (France)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Dopamine release; Dopaminergic neuron firing rate; GR 125487; Microdialysis; Rat

Indexed keywords

5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; DOPAMINE; HALOPERIDOL; HALOTHANE; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FACILITATION; IN VIVO STUDY; MALE; MICRODIALYSIS; NERVE CONDUCTION; NEUROCHEMISTRY; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM;

ACTION POTENTIALS; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EXTRACELLULAR SPACE; HALOPERIDOL; INDOLES; MALE; NEOSTRIATUM; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; RAPHE NUCLEI; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA; SULFONAMIDES; VENTRAL TEGMENTAL AREA;

EID: 0035105390     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2000.01453.x     Document Type: Article

References (59)

1. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat
2. A review of central 5-HT receptors and their function
3. 4 splice variant
4. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization
5. 4 receptor isoforms produced by alternative splicing in the carboxyl terminus
6. 4 receptor: A place in the sun
7. Mapping of serotonin 5-HT (4) receptor mRNA and ligand binding sites in the post-mortem human brain
8. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: A microdialysis study in the halothane-anesthetized rat
9. [3H]1,3-di (2-tolyl) guanidine and [3H] (+) pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes
10. Dopaminergic neurons: Effects of antipsychotic drugs and amphetamine on single cell activity
11. 4 receptors in rat basal ganglia and hippocampus
12. 4 receptors indirectly enhances in vivo dopamine release in the rat striatum
13. 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation
14. 3 receptors
15. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: A combined in vivo electrophysiological and microdialysis study
16. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system
17. 4 receptor positively coupled to adenylate cyclase in brain
18. 4) receptors
19. 4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo
20. 4 receptor
21. 4 receptor antagonist
22. 4 receptor: Molecular cloning and pharmacological characterization of two splice variants
23. Nigral dopamine neurons: Intracellular recording and identification with L-DOPA injection and histofluorescence
24. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity
25. 4 receptors in guinea-pig and rat brain
26. Basal ganglia
27. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens
28. In vivo neurochemeical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy
29. 3H]BIMU-1
30. Dissociative anesthesia and striatal neuronal electrophysiology
31. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
32. 4 receptors improve social olfactory memory in the rat
33. Acute administration of haloperidol enhances dopaminergic transmission
34. 2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release
35. 2C receptor subtypes and significance of the haloperidol dose used
36. 2 receptors in the dorsal raphe nucleus increases firing rate and 5-HT release in the rat brain
37. 4 receptors in the nucleus accumbens shell
38. Dopaminergic input is required for increases in serotonin output produced by behavioral activation: An in vivo microdialysis study in rat forebrain
39. General anesthetics prevent dopaminergic neuron stimulation by neuroleptics
40. Localization of Serotonin-4 receptors in the striatonigral pathway in the rat brain
41. The Rat Brain in Stereotaxic Coordinates. 2nd edn
42. Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169369, cisapride and granisetron on neuroleptic-induced catalepsy in mice
43. 4 receptor antagonist, attenuates morphine-stimulated dopamine release in the rat striatum
44. 4 receptors antagonism does not affect motor and reward mechanisms in the rat
45. 4 receptors in post mortem human brain tissue: Distribution, pharmacology and effects of neurodegenerative diseases
46. Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake
47. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors
48. 4 recognition sites in the porcine caudate nucleus by radioligand binding
49. 2 receptors exert a state dependant regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-Methylenedioxymethamphetamine
50. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography
51. Aggravation of parkinsonian tremor by cisapride
52. Apomorphine and haloperidol effects on striatal dopamine release in anasthetized, awake, restrained and freely moving rats
53. 4 receptor ligands to modulate rat striatal dopamine release in vitro or in vivo
54. 4 agonists on dopamine levels measured from the nucleus accumbens and striatum: An in vivo microdialysis study in freely-moving rats
55. 4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: A microdialysis study
56. 4 receptor mRNA in rat brain by in situ hybridization histochemistry
57. 4 binding sites in rodent brain
58. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization
59. Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors